Five years after surgery, in 78% of the patients the cancer had not progressed (increase in size or spread), a percentage that had only been reduced to 75% after ten years, while mortality in this last period decreased. was around 2%. The cancer only progressed in 175 patients, in half of the cases within the first year after the intervention, and in only nine men after five years.
The authors highlight the reliability of all these results, even though they do not come from a controlled study. In any case, they also warn that they cannot necessarily be extrapolated to other centers and other professionals.
